Roger S. McIntyre, MD, FRCPC
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Ontario, Canada
- 87Articles
- 534.1KReads
- 2001–2026Active
- 223Collaborators
- 2.3KCitations
About
Roger S. McIntyre is affiliated with the Department of Psychiatry and the Department of Pharmacology and Toxicology at the University of Toronto. With a publication record spanning from 2001 to 2026, McIntyre has contributed extensively to clinical topics including major depressive disorder, bipolar disorder, schizophrenia and schizoaffective disorders, child and adolescent psychiatry, patient care, weight management, cognition, and neurology. His work explores pharmacodynamic effects following antidepressant cessation, the role of GLP-1 receptor agonists in psychiatric treatment, metabolic dysfunction screening in severe mental disorders, and innovations in precision psychiatry. McIntyre frequently collaborates with authors such as Michael E. Thase and Christoph U. Correll.
Publications
Prevalence and Treatment of Depression in Children and Adolescents With Sickle Cell Disease: A Retrospective Cohort Study
March 10, 2011
Metabolic, Digestive, and Reproductive Adverse Events Associated With Antimanic Treatment in Children and Adolescents: A Retrospective Cohort Study
July 8, 2010
Attention-Deficit/Hyperactivity Disorder in Adults With Bipolar Disorder or Major Depressive Disorder: Results From the International Mood Disorders Collaborative Project
May 27, 2010
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
